
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
Showing 15 citing articles:
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6
An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease
Serena Altamura, Davide Pietropaoli, Francesca Lombardi, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3033-3033
Open Access | Times Cited: 15
Serena Altamura, Davide Pietropaoli, Francesca Lombardi, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3033-3033
Open Access | Times Cited: 15
THE ROLE OF ALLULOSE AND SUGAR ALCOHOLS IN GUT MICROBIOTA MODULATION AND METABOLIC HEALTH: A REVIEW
Mostafa Essam Eissa
Universal Journal of Pharmaceutical Research (2025)
Open Access
Mostafa Essam Eissa
Universal Journal of Pharmaceutical Research (2025)
Open Access
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study
Yi Han, Yuzhuo Wang, Xing Yu Zhu, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Yi Han, Yuzhuo Wang, Xing Yu Zhu, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
The Link between Gut Microbiome, Nutraceuticals, Diet, and Diabetes Mellitus: A Bibliometric and Visual Analysis of Research and Emerging Trends from 2012 to 2022
Aparajita Sarkar, Anfal Sher Khan, Ridhima Kaul, et al.
(2024)
Open Access | Times Cited: 3
Aparajita Sarkar, Anfal Sher Khan, Ridhima Kaul, et al.
(2024)
Open Access | Times Cited: 3
Exploring the Impact of Optimized Probiotic Supplementation Techniques on Diabetic Nephropathy: Mechanisms and Therapeutic Potential
Anindita Ghosh, Arti Muley, Archana S Ainapure, et al.
Cureus (2024)
Open Access | Times Cited: 2
Anindita Ghosh, Arti Muley, Archana S Ainapure, et al.
Cureus (2024)
Open Access | Times Cited: 2
Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy
Farideh Ghavidel, Hamed Amiri, Masoud Homayouni Tabrizi, et al.
Current Developments in Nutrition (2023) Vol. 8, Iss. 1, pp. 102059-102059
Open Access | Times Cited: 6
Farideh Ghavidel, Hamed Amiri, Masoud Homayouni Tabrizi, et al.
Current Developments in Nutrition (2023) Vol. 8, Iss. 1, pp. 102059-102059
Open Access | Times Cited: 6
Probiotics mitigate kidney damage after exposure to Sri Lanka's local groundwater from chronic kidney disease with uncertain etiology (CKDu) prevalent area in zebrafish
Ling-Kang Bu, Pan‐Pan Jia, LI Wei-guo, et al.
Aquatic Toxicology (2023) Vol. 262, pp. 106671-106671
Closed Access | Times Cited: 5
Ling-Kang Bu, Pan‐Pan Jia, LI Wei-guo, et al.
Aquatic Toxicology (2023) Vol. 262, pp. 106671-106671
Closed Access | Times Cited: 5
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 4
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 4
The Efficacy and Safety of Probiotic Combinations Lobun Forte® Versus Renadyl® in Patients With Chronic Kidney Disease: A Comparative, Phase IV, Randomized, Open-Label, Active-Controlled, Parallel Study
Raja Karthik Kalidindi, C. Prabhakar Reddy, Kishan Pv, et al.
Cureus (2024)
Open Access | Times Cited: 1
Raja Karthik Kalidindi, C. Prabhakar Reddy, Kishan Pv, et al.
Cureus (2024)
Open Access | Times Cited: 1
The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103118-103118
Open Access | Times Cited: 1
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103118-103118
Open Access | Times Cited: 1
Progression of Diabetic Kidney Disease and Gastrointestinal Symptoms in Patients with Type I Diabetes
Aleksejs Fedulovs, Lilian Tzivian, Polina Zaļizko, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2679-2679
Open Access | Times Cited: 3
Aleksejs Fedulovs, Lilian Tzivian, Polina Zaļizko, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2679-2679
Open Access | Times Cited: 3
Gut microbiota and kidney diseases. Literature review
Evgeny Shutov, Bolshakov S.A. Bolshakov, Tatyana A Makarova, et al.
Nephrology and Dialysis (2024) Vol. 26, Iss. 3, pp. 283-302
Closed Access
Evgeny Shutov, Bolshakov S.A. Bolshakov, Tatyana A Makarova, et al.
Nephrology and Dialysis (2024) Vol. 26, Iss. 3, pp. 283-302
Closed Access
Progression of Diabetic Kidney Disease and Gastrointestinal Symptoms in Patients with Type I Diabetes
Aleksejs Fedulovs, Lilian Tzivian, Polina Zaļizko, et al.
(2023)
Open Access | Times Cited: 1
Aleksejs Fedulovs, Lilian Tzivian, Polina Zaļizko, et al.
(2023)
Open Access | Times Cited: 1